10/4
04:15 pm
cyto
Altamira Therapeutics receives Nasdaq non-compliance letter [Seeking Alpha]
Medium
Report
Altamira Therapeutics receives Nasdaq non-compliance letter [Seeking Alpha]
10/4
04:01 pm
cyto
Altamira Therapeutics Provides Update on Nasdaq Listing
Medium
Report
Altamira Therapeutics Provides Update on Nasdaq Listing
9/27
09:01 am
cyto
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Low
Report
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
9/24
08:01 am
cyto
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Medium
Report
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
9/23
03:17 am
cyto
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia [Yahoo! Finance]
Medium
Report
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia [Yahoo! Finance]
9/23
03:00 am
cyto
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia
Medium
Report
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia
9/20
09:01 am
cyto
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
Low
Report
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
9/19
04:01 pm
cyto
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
Medium
Report
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
9/17
05:00 pm
cyto
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
Low
Report
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
9/16
08:30 am
cyto
Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
High
Report
Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
9/3
09:16 am
cyto
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 [Yahoo! Finance]
Low
Report
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 [Yahoo! Finance]
9/3
09:06 am
cyto
Family-owned Tropical Cheese is exploring a sale, sources say [Yahoo! Finance Canada]
Low
Report
Family-owned Tropical Cheese is exploring a sale, sources say [Yahoo! Finance Canada]
9/3
09:01 am
cyto
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11
Medium
Report
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11
8/26
10:49 am
cyto
REPEAT -- Diamond Equity Research Releases Update Note on Altamira Therapeutics Ltd. (NASDAQ: CYTO) [Yahoo! Finance]
Low
Report
REPEAT -- Diamond Equity Research Releases Update Note on Altamira Therapeutics Ltd. (NASDAQ: CYTO) [Yahoo! Finance]